PinPointe FootLaser: PathoLase, Inc. and PinPointe USA, Inc. to be Established as Separate Corporate Entities

Published: Aug 12, 2009

CHICO, Calif.--(BUSINESS WIRE)--PathoLase, Inc., which introduced the PinPointe™ FootLaser™ treatment for toenail fungus (onychymycosis), today announced it is establishing two separate corporate entities: PathoLase, Inc., which will continue to work on development of new laser-based medical devices for the treatment of targeted infections; and PinPointe USA, Inc., which will focus entirely on expanding the groundbreaking PinPointe FootLaser treatment.

Back to news